# Theravance Biopharma, Inc. (TBPH) — merger/definitive [pending]
Source: SEC API (secapi.ai) · situation sit_73fdff204decfd6ee48f · retrieved 2026-08-14T01:24:11.555Z

## Overview
Theravance Biopharma, Inc. develops and commercializes respiratory medicines, including YUPELRI® (revefenacin), a once-daily nebulized long-acting muscarinic antagonist (LAMA) bronchodilator approved for maintenance treatment of chronic obstructive pulmonary disease (COPD).

On June 29, 2026, Theravance Biopharma announced a definitive agreement to be acquired by Zymeworks Inc. for $17.00 per share in cash, plus a contingent value right (CVR) entitling shareholders to 80% of net proceeds from any future license, divestiture, or other monetization of ampreloxetine over the next ten years. The transaction is expected to close in the second half of 2026, subject to shareholder approval and customary closing conditions.

## Terms
- Counterparty: Zymeworks Inc. · Consideration: mixed · Price/share: $17

## Key dates
- Announced 2026-08-10 · Expected close 2026-12-31

## Timeline
- 2026-08-10 · 8-K (0001104659-26-093066): 8-K - Theravance Biopharma, Inc. — *Theravance Biopharma, Inc. develops and commercializes respiratory medicines, including YUPELRI® (revefenacin), a once-daily nebulized long-acting muscarinic antagonist (LAMA) bronchodilator approved for maintenance treatment of chronic obstructive pulmonary disease (COPD).* On June 29, 2026, Theravance Biopharma announced a definitive agreement to be acquired by Zymeworks Inc. for $17.00 per share in cash, plus a contingent value right (CVR) entitling shareholders to 80% of net proceeds from any future license, divestiture, or other monetization of ampreloxetine over the next ten years. The transaction is expected to close in the second half of 2026, subject to shareholder approval and customary closing conditions.
  https://www.sec.gov/Archives/edgar/data/1583107/0001104659-26-093066.txt

## Citations
- 0001104659-26-093066 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926093066